PYXS
Pyxis Oncology Inc
NASDAQ: PYXS · HEALTHCARE · BIOTECHNOLOGY
$1.70
+2.41% today
Updated 2026-04-30
Market cap
$106.81M
P/E ratio
—
P/S ratio
7.71x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$1 – $6
Volume
0.4M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+2.5
Profitability
F4.0
Valuation
C—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$6.88
+304.71%
12-Month target
—
—
Intrinsic (DCF)
$0.95
Margin of safety
-42.11%
1 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-10.43M
- 42.11% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $16.15M | $13.86M | $13.86M |
| Net income | $-117.95M | $-73.79M | $-77.33M | $-79.62M | $-18.11M |
| EPS | — | — | — | — | $-1.28 |
| Free cash flow | $-95.73M | $-77.44M | $-57.91M | $-63.51M | $-10.43M |
| Profit margin | — | — | -478.95% | -574.55% | — |
Peer comparison
Smart narrative
Pyxis Oncology Inc trades at $1.70. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $13.86M. Our DCF model estimates intrinsic value at $0.95.
Frequently asked questions
What is Pyxis Oncology Inc's stock price?
Pyxis Oncology Inc (PYXS) trades at $1.70.
Is Pyxis Oncology Inc overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell). DCF value $0.95.
What is the price target of Pyxis Oncology Inc (PYXS)?
The analyst target price is $6.88, representing +304.7% upside from the current price of $1.70.
What is the intrinsic value of Pyxis Oncology Inc (PYXS)?
Based on our DCF model, intrinsic value is $0.95, a -42.1% margin of safety versus $1.70.
What is Pyxis Oncology Inc's revenue?
TTM revenue is $13.86M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio7.71x
ROE-91.40%
Beta1.42
50D MA$1.54
200D MA$2.16
Shares out0.06B
Float0.04B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—